Clinical Nutrition, 40(3)
28, 2025, semaglutide (Ozempic) received FDA approval to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to cardiovascular disease (CVD) in adults with type 2 diabetes (T2DM) and chronic kidney disease (CKD)
In short, Wegovy and Ozempic are essentially identical medications under different brand names, with the primary difference lying in the dosage of semaglutide in each injection pen and the specific approvals granted for their use
People lose an average 8% of their starting weight in 56 weeks on the maintenance dose
See where to inject GLOW peptide for the full anatomical breakdown
No, the doses for tirzepatide and semaglutide are not equivalent on a milligram-to-milligram basis